Work

Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

Year: 2012

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.126.suppl_21.a19281

Authors: Jonathan P Piccini, Susanna Stevens, Yuliya Lokhnygina, Manesh Patel, Daniel Singer, Jonathan Halperin, Graeme Hankey, Werner Hacke, Richard Becker, Christopher Nessel, Kenneth Mahaffey, Keith Fox, Robert Califf, Gúnter Breithardt

Institutions: Duke University, Duke Medical Center, Harvard University, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Royal Perth Hospital, Heidelberg University, Janssen Research & Development (United States), University of Edinburgh, University of Münster, University Hospital Münster

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W207004634

Cites:

Cited by: 6

Related to: 10